Stay updated on Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the number of patients expected to be included in the study evaluating the efficacy and safety of fruquintinib as a maintenance therapy following first-line treatment for metastatic colorectal cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:37:11.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying age range, performance score, estimated survival, and specific health conditions. Previously, no information was provided in this section.
    Difference
    38%
    Check dated 2024-05-22T21:22:05.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:51:57.000Z thumbnail image

Stay in the know with updates to Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial page.